(ALNY) Alnylam Pharmaceuticals complete technical analysis [charts+indicators] | Buy/Sell Alnylam Pharmaceuticals | (ALNY) share price targets
Complete technical analysis of Alnylam Pharmaceuticals (ALNY) by charts plus indicators, forecast predictions and share price targets for Alnylam Pharmaceuticals (ALNY)
Alnylam Pharmaceuticals trades in USA in Health Care sector.
Showing technical analysis as on 2024-05-17 View latest technical analysis
10 day averaged volume of Alnylam Pharmaceuticals is 478697
| Date | Daily Closing Price | Open | High | Low | Volume |
| 17 Fri May 2024 | 149.40 | 151.03 | 151.84 | 148.32 | 0.851 times |
| 16 Thu May 2024 | 151.22 | 147.15 | 151.45 | 144.73 | 1.951 times |
| 15 Wed May 2024 | 147.40 | 149.50 | 150.15 | 146.97 | 1.12 times |
| 14 Tue May 2024 | 147.89 | 150.81 | 151.63 | 147.02 | 1.264 times |
| 13 Mon May 2024 | 149.89 | 151.28 | 152.67 | 149.00 | 1.071 times |
| 10 Fri May 2024 | 150.47 | 151.81 | 151.81 | 148.75 | 0.674 times |
| 09 Thu May 2024 | 151.37 | 153.00 | 153.00 | 150.37 | 0.688 times |
| 08 Wed May 2024 | 152.29 | 154.08 | 155.49 | 152.19 | 0.945 times |
| 07 Tue May 2024 | 154.33 | 152.42 | 155.11 | 150.83 | 0.738 times |
| 06 Mon May 2024 | 151.22 | 152.82 | 152.82 | 149.52 | 0.605 times |
My analysis of stock is bullish for shortterm, and stock might move up till 151.8 or till 155.7. Use a stoploss of 148.6 and if this stock hits its stoploss, then it can fall down till 145.39
Share price targets for Alnylam Pharmaceuticals (ALNY)
| Target Type | Value |
| Downside Target | 141.98 |
| Downside Target | 148.75 |
| Upside Target | 152.67 |
| Upside Target | 155.41 |
| Upside Target | 155.49 |
| Upside Target | 155.91 |
| Upside Target | 159.34 |
| Upside Target | 172.37 |
| Upside Target | 176.35 |
| Upside Target | 199.38 |
Intraday share price targets for Alnylam Pharmaceuticals (ALNY)
| Target Type | Value |
| Downside Intraday Target | 145.2 |
| Downside Intraday Target | 140.99 |
| Upside Intraday Target | 153.14 |
| Upside Intraday Target | 156.87 |
| Downside Intraday Target | 148.93 |
Weekly technical analysis of Alnylam Pharmaceuticals (ALNY)
| Date | Weekly Closing Price | Open | High | Low | Volume |
| 17 Fri May 2024 | 149.40 | 151.28 | 152.67 | 144.73 | 1.714 times |
| 10 Fri May 2024 | 150.47 | 152.82 | 155.49 | 148.75 | 0.632 times |
| 03 Fri May 2024 | 152.33 | 144.91 | 155.41 | 143.50 | 1.198 times |
| 26 Fri Apr 2024 | 143.31 | 145.21 | 150.27 | 141.98 | 0.903 times |
| 19 Fri Apr 2024 | 144.41 | 148.62 | 150.37 | 143.50 | 0.91 times |
Price has moved down this week, and volume has increased substantially. This means that the move can continue in coming weeks.
Monthly technical analysis of Alnylam Pharmaceuticals (ALNY)
| Date | Monthly Closing Price | Open | High | Low | Volume |
| 17 Fri May 2024 | 149.40 | 144.21 | 155.49 | 143.96 | 0.613 times |
| 30 Tue Apr 2024 | 143.95 | 148.57 | 159.34 | 141.98 | 0.834 times |
| 28 Thu Mar 2024 | 149.45 | 150.90 | 155.91 | 143.66 | 0.461 times |
| 29 Thu Feb 2024 | 151.09 | 173.54 | 176.35 | 143.52 | 2.224 times |
Scroll below to view daily charts
Price has moved up this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Alnylam Pharmaceuticals (ALNY)
Price action analysis of Alnylam Pharmaceuticals ( (ALNY) ) based on a short term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
Price action analysis of Alnylam Pharmaceuticals ( (ALNY) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Alnylam Pharmaceuticals ( (ALNY) ) based on a short to mid term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Alnylam Pharmaceuticals ( (ALNY) ) based on a mid to longer term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
ADX buy sell signal for Alnylam Pharmaceuticals stock for short term is SELL. Signal strength is Weak and stock is losing momentum.
MACD generated a BUY signal for Alnylam Pharmaceuticals in short term but the buy signal is initial and weak.
Alnylam Pharmaceuticals Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of red color and prices are in or above the red cloud Prices appear to be coming down
CCI has generated a buy signal for Alnylam Pharmaceuticals in short term but BUY signal is weak.
RSI is generating a BUY signal in short term but buying is losing momentum.
MRSI is in positive zone. This is a BUY zone
Stock of Alnylam Pharmaceuticals is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 150.36 and Alnylam Pharmaceuticals (ALNY) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Alnylam Pharmaceuticals (ALNY) stock. Volume based technical analysis of Alnylam Pharmaceuticals (ALNY) stock is negative.
Alnylam Pharmaceuticals Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Alnylam Pharmaceuticals ( (ALNY) ) based on a short term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
Price action analysis of Alnylam Pharmaceuticals ( (ALNY) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Alnylam Pharmaceuticals ( (ALNY) ) based on a short to mid term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Alnylam Pharmaceuticals ( (ALNY) ) based on a mid to longer term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
ADX buy sell signal for Alnylam Pharmaceuticals stock for short term is SELL. Signal strength is Weak and stock is losing momentum.
MACD generated a BUY signal for Alnylam Pharmaceuticals in short term but the buy signal is initial and weak.
Alnylam Pharmaceuticals Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of red color and prices are in or above the red cloud Prices appear to be coming down
CCI has generated a buy signal for Alnylam Pharmaceuticals in short term but BUY signal is weak.
RSI is generating a BUY signal in short term but buying is losing momentum.
MRSI is in positive zone. This is a BUY zone
Stock of Alnylam Pharmaceuticals is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 150.36 and Alnylam Pharmaceuticals (ALNY) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Alnylam Pharmaceuticals (ALNY) stock. Volume based technical analysis of Alnylam Pharmaceuticals (ALNY) stock is negative.
Alnylam Pharmaceuticals Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.